189 related articles for article (PubMed ID: 28382379)
1. Posttreatment DSC-MRI is Predictive of Early Treatment Failure in Children with Supratentorial High-Grade Glioma Treated with Erlotinib.
Lucas JT; Knapp BJ; Uh J; Hua CH; Merchant TE; Hwang SN; Patay Z; Broniscer A
Clin Neuroradiol; 2018 Sep; 28(3):393-400. PubMed ID: 28382379
[TBL] [Abstract][Full Text] [Related]
2. Comparative study of pulsed-continuous arterial spin labeling and dynamic susceptibility contrast imaging by histogram analysis in evaluation of glial tumors.
Arisawa A; Watanabe Y; Tanaka H; Takahashi H; Matsuo C; Fujiwara T; Fujiwara M; Fujimoto Y; Tomiyama N
Neuroradiology; 2018 Jun; 60(6):599-608. PubMed ID: 29705876
[TBL] [Abstract][Full Text] [Related]
3. Arterial Spin-Labeling and DSC Perfusion Metrics Improve Agreement in Neuroradiologists' Clinical Interpretations of Posttreatment High-Grade Glioma Surveillance MR Imaging-An Institutional Experience.
Yamin G; Tranvinh E; Lanzman BA; Tong E; Hashmi SS; Patel CB; Iv M
AJNR Am J Neuroradiol; 2024 Apr; 45(4):453-460. PubMed ID: 38453410
[TBL] [Abstract][Full Text] [Related]
4. Assessment of brain tumors by magnetic resonance dynamic susceptibility contrast perfusion-weighted imaging and computed tomography perfusion: a comparison study.
Scola E; Desideri I; Bianchi A; Gadda D; Busto G; Fiorenza A; Amadori T; Mancini S; Miele V; Fainardi E
Radiol Med; 2022 Jun; 127(6):664-672. PubMed ID: 35441970
[TBL] [Abstract][Full Text] [Related]
5. Treatment monitoring in gliomas: comparison of dynamic susceptibility-weighted contrast-enhanced and spectroscopic MRI techniques for identifying treatment failure.
Vöglein J; Tüttenberg J; Weimer M; Gerigk L; Kauczor HU; Essig M; Weber MA
Invest Radiol; 2011 Jun; 46(6):390-400. PubMed ID: 21285888
[TBL] [Abstract][Full Text] [Related]
6. Perfusion MRI as the predictive/prognostic and pharmacodynamic biomarkers in recurrent malignant glioma treated with bevacizumab: a systematic review and a time-to-event meta-analysis.
Choi SH; Jung SC; Kim KW; Lee JY; Choi Y; Park SH; Kim HS
J Neurooncol; 2016 Jun; 128(2):185-94. PubMed ID: 27108275
[TBL] [Abstract][Full Text] [Related]
7. Advanced and amplified BOLD fluctuations in high-grade gliomas.
Gupta L; Gupta RK; Postma AA; Sahoo P; Gupta PK; Patir R; Ahlawat S; Saha I; Backes WH
J Magn Reson Imaging; 2018 Jun; 47(6):1616-1625. PubMed ID: 28963852
[TBL] [Abstract][Full Text] [Related]
8. Analysis of postprocessing steps for residue function dependent dynamic susceptibility contrast (DSC)-MRI biomarkers and their clinical impact on glioma grading for both 1.5 and 3T.
Bell LC; Stokes AM; Quarles CC
J Magn Reson Imaging; 2020 Feb; 51(2):547-553. PubMed ID: 31206948
[TBL] [Abstract][Full Text] [Related]
9. Pediatric astrocytic tumor grading: comparison between arterial spin labeling and dynamic susceptibility contrast MRI perfusion.
Morana G; Tortora D; Staglianò S; Nozza P; Mascelli S; Severino M; Piatelli G; Consales A; Lequin M; Garrè ML; Rossi A
Neuroradiology; 2018 Apr; 60(4):437-446. PubMed ID: 29453753
[TBL] [Abstract][Full Text] [Related]
10. Dynamic susceptibility contrast and dynamic contrast-enhanced MRI characteristics to distinguish microcystic meningiomas from traditional Grade I meningiomas and high-grade gliomas.
Hussain NS; Moisi MD; Keogh B; McCullough BJ; Rostad S; Newell D; Gwinn R; Foltz G; Mayberg M; Aguedan B; Good V; Fouke SJ
J Neurosurg; 2017 Apr; 126(4):1220-1226. PubMed ID: 27285539
[TBL] [Abstract][Full Text] [Related]
11. Dynamic contrast-enhanced and dynamic susceptibility contrast perfusion MR imaging for glioma grading: Preliminary comparison of vessel compartment and permeability parameters using hotspot and histogram analysis.
Santarosa C; Castellano A; Conte GM; Cadioli M; Iadanza A; Terreni MR; Franzin A; Bello L; Caulo M; Falini A; Anzalone N
Eur J Radiol; 2016 Jun; 85(6):1147-56. PubMed ID: 27161065
[TBL] [Abstract][Full Text] [Related]
12. [Perfusion measurement using the T2* contrast media dynamics in neuro-oncology. Physical basics and clinical applications].
Weber MA; Risse F; Giesel FL; Schad LR; Kauczor HU; Essig M
Radiologe; 2005 Jul; 45(7):618-32. PubMed ID: 15098092
[TBL] [Abstract][Full Text] [Related]
13. Voxel-based evidence of perfusion normalization in glioblastoma patients included in a phase I-II trial of radiotherapy/tipifarnib combination.
Ken S; Deviers A; Filleron T; Catalaa I; Lotterie JA; Khalifa J; Lubrano V; Berry I; Péran P; Celsis P; Moyal EC; Laprie A
J Neurooncol; 2015 Sep; 124(3):465-73. PubMed ID: 26189058
[TBL] [Abstract][Full Text] [Related]
14. Utility of intravoxel incoherent motion magnetic resonance imaging and arterial spin labeling for recurrent glioma after bevacizumab treatment.
Miyoshi F; Shinohara Y; Kambe A; Kuya K; Murakami A; Kurosaki M; Ogawa T
Acta Radiol; 2018 Nov; 59(11):1372-1379. PubMed ID: 29471670
[TBL] [Abstract][Full Text] [Related]
15. Reliable estimation of microvascular flow patterns in patients with disrupted blood-brain barrier using dynamic susceptibility contrast MRI.
Hansen MB; Tietze A; Kalpathy-Cramer J; Gerstner ER; Batchelor TT; Østergaard L; Mouridsen K
J Magn Reson Imaging; 2017 Aug; 46(2):537-549. PubMed ID: 27902858
[TBL] [Abstract][Full Text] [Related]
16. Diagnostic Accuracy of Arterial Spin-Labeling, Dynamic Contrast-Enhanced, and DSC Perfusion Imaging in the Diagnosis of Recurrent High-Grade Gliomas: A Prospective Study.
Nguyen TB; Zakhari N; Velasco Sandoval S; Guarnizo-Capera A; Alexios Gulak M; Woulfe J; Jansen G; Thornhill R; Majtenyi N; Cron GO
AJNR Am J Neuroradiol; 2023 Feb; 44(2):134-142. PubMed ID: 36702501
[TBL] [Abstract][Full Text] [Related]
17. Post-treatment changes of tumour perfusion parameters can help to predict survival in patients with high-grade astrocytoma.
Sanz-Requena R; Revert-Ventura AJ; García-Martí G; Salamé-Gamarra F; Pérez-Girbés A; Mollá-Olmos E; Martí-Bonmatí L
Eur Radiol; 2017 Aug; 27(8):3392-3400. PubMed ID: 27999986
[TBL] [Abstract][Full Text] [Related]
18. Differentiation of grade II/III and grade IV glioma by combining "T1 contrast-enhanced brain perfusion imaging" and susceptibility-weighted quantitative imaging.
Saini J; Gupta PK; Sahoo P; Singh A; Patir R; Ahlawat S; Beniwal M; Thennarasu K; Santosh V; Gupta RK
Neuroradiology; 2018 Jan; 60(1):43-50. PubMed ID: 29090331
[TBL] [Abstract][Full Text] [Related]
19. Arterial spin labeling: Pathologically proven superiority over conventional MRI for detection of high-grade glioma progression after treatment.
Nyberg E; Honce J; Kleinschmidt-DeMasters BK; Shukri B; Kreidler S; Nagae L
Neuroradiol J; 2016 Oct; 29(5):377-83. PubMed ID: 27542895
[TBL] [Abstract][Full Text] [Related]
20. Biopsy targeting gliomas: do functional imaging techniques identify similar target areas?
Weber MA; Henze M; Tüttenberg J; Stieltjes B; Meissner M; Zimmer F; Burkholder I; Kroll A; Combs SE; Vogt-Schaden M; Giesel FL; Zoubaa S; Haberkorn U; Kauczor HU; Essig M
Invest Radiol; 2010 Dec; 45(12):755-68. PubMed ID: 20829706
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
